Metyrosine (Demser®) for the Treatment of Psychotic Disorders in Patients With Velocardiofacial Syndrome

NCT01127503 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

2

Enrollment

INDUSTRY

Sponsor class

Stopped Enrollment, study-design and execution challenges.

Conditions

Velo-cardio-facial Syndrome
Psychosis

Interventions

DRUG: Metyrosine
DRUG: Placebo

Sponsor

Bausch Health Americas, Inc.